The legal battle over mifepristone, the most widely used abortion medication in the nation, is heating up American women and doctors are, once again, experiencing whiplash as the court system has revoked and restored access to the most widely used abortion medication in the country — and is poised to strip it away once more — all in the span of a week and a half. Last Friday, the Fifth Circuit Court of Appeals issued a ruling in Louisiana v. FDA, prohibiting abortion providers from mailing mifepristone , the first drug taken as part of the typical two-step medication abortion protocol, to patients anywhere in the county. The following Monday, the Supreme Court temporarily reinstated access to the medication at the request of two of the drug’s manufacturers, Danco Labs and GenBioPro. That temporary order is set to expire this coming Monday; if the court doesn’t act before then, women across the country will once again be unable to receive the critical drug through the mail.…